Page last updated: 2024-09-05

tesaglitazar and metformin

tesaglitazar has been researched along with metformin in 4 studies

Compound Research Comparison

Studies (tesaglitazar)	Trials (tesaglitazar)	Recent Studies (post-2010) (tesaglitazar)	Studies (metformin)	Trials (metformin)	Recent Studies (post-2010) (metformin)
74	13	25	17,793	3,176	12,526

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Gause-Nilsson, I; Göke, B; Persson, A	1

Trials

1 trial(s) available for tesaglitazar and metformin

Article	Year
The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes. Diabetes & vascular disease research, 2007, Volume: 4, Issue:3 Topics: Adult; Aged; Alkanesulfonates; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Phenylpropionates; PPAR alpha; PPAR gamma; Time Factors	2007

Article

Year

The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes.

Diabetes & vascular disease research, 2007, Volume: 4, Issue:3

Topics: Adult; Aged; Alkanesulfonates; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Phenylpropionates; PPAR alpha; PPAR gamma; Time Factors

2007

Other Studies

3 other study(ies) available for tesaglitazar and metformin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010